Literature DB >> 9693802

Neuronal and glial expression of heparin-binding EGF-like growth factor in central nervous system of prenatal and early-postnatal rat.

T Nakagawa1, M Sasahara, Y Hayase, M Haneda, H Yasuda, R Kikkawa, S Higashiyama, F Hazama.   

Abstract

We investigated heparin-binding epidermal growth factor-like growth factor (HB-EGF) gene and protein expression in the central nervous system of prenatal and early postnatal rats. Assay by northern blot analysis showed that the HB-EGF mRNA was markedly expressed in the brain. In situ hybridization and immunohistochemical techniques showed that concordant expression of HB-EGF mRNA and protein was widely observed in the neurons and interfascicular oligodendrocytes, especially in the cerebellum, the hippocampus, the cerebral cortex, the subventricular area, and the brain stem nuclei. The intense expression of the HB-EGF mRNA was related anatomically and temporally to the proliferating neuroblasts in the external granular layer of the cerebellum and the subventricular layer of the cerebrum. These findings suggest that HB-EGF acts as a mitogen for the neuroblasts. Moreover, HB-EGF expression was observed in the post-mitogenic cells, such as in the cells of the molecular layer, the white matter, the IGL, or the Purkinje cells of the cerebellum. Since EGF receptors are abundantly expressed in the post-mitogenic period, the HB-EGF mRNA expression observed in the post-mitogenic period in our study suggests that HB-EGF also has a non-mitogenic function. These results suggest that HB-EGF significantly contributes to the development of the brain.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9693802     DOI: 10.1016/s0165-3806(98)00057-1

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  12 in total

Review 1.  Roles of transforming growth factor-alpha and related molecules in the nervous system.

Authors:  C J Xian; X F Zhou
Journal:  Mol Neurobiol       Date:  1999 Oct-Dec       Impact factor: 5.590

2.  Heparin-binding EGF-like growth factor promotes neuronal nitric oxide synthase expression and protects the enteric nervous system after necrotizing enterocolitis.

Authors:  Yu Zhou; Yijie Wang; Jacob Olson; Jixin Yang; Gail E Besner
Journal:  Pediatr Res       Date:  2017-05-24       Impact factor: 3.756

3.  Preclinical Pharmacokinetics Evaluation of Anti-heparin-binding EGF-like Growth Factor (HB-EGF) Monoclonal Antibody Using Cynomolgus Monkeys via (89)Zr-immuno-PET Study and the Determination of Drug Concentrations in Serum and Cerebrospinal Fluid.

Authors:  Noriyuki Kasai; Maiko Adachi; Kazuya Yamano
Journal:  Pharm Res       Date:  2015-10-13       Impact factor: 4.200

4.  Role of PDGF B-chain and PDGF receptors in rat tubular regeneration after acute injury.

Authors:  T Nakagawa; M Sasahara; M Haneda; H Kataoka; H Nakagawa; M Yagi; R Kikkawa; F Hazama
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

5.  Heparin-binding epidermal growth factor-like growth factor is a potent neurotrophic factor for PC12 cells.

Authors:  Yu Zhou; Gail E Besner
Journal:  Neurosignals       Date:  2010-09-16

6.  N-syndecan deficiency impairs neural migration in brain.

Authors:  Anni Hienola; Sarka Tumova; Evgeny Kulesskiy; Heikki Rauvala
Journal:  J Cell Biol       Date:  2006-08-14       Impact factor: 10.539

7.  Heparin-binding epidermal growth factor-like growth factor: hypoxia-inducible expression in vitro and stimulation of neurogenesis in vitro and in vivo.

Authors:  Kunlin Jin; Xiao Ou Mao; Yunjuan Sun; Lin Xie; Lan Jin; Eiichiro Nishi; Michael Klagsbrun; David A Greenberg
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

8.  Signalling pathways for transactivation by dexmedetomidine of epidermal growth factor receptors in astrocytes and its paracrine effect on neurons.

Authors:  B Li; T Du; H Li; L Gu; H Zhang; J Huang; L Hertz; L Peng
Journal:  Br J Pharmacol       Date:  2008-03-03       Impact factor: 8.739

9.  Phase 1 Study of Monotherapy with KHK2866, an Anti-Heparin-Binding Epidermal Growth Factor-Like Growth Factor Monoclonal Antibody, in Patients with Advanced Cancer.

Authors:  John Sarantopoulos; Monica M Mita; Michael J Birrer; Lee D Cranmer; Luis T Campos; Xiaoping Zhang; Penelope Bristow; Hidekuni Kaito; Vincent Strout; Luis H Camacho
Journal:  Target Oncol       Date:  2016-06       Impact factor: 4.493

10.  Generation and characterization of conditional heparin-binding EGF-like growth factor knockout mice.

Authors:  Atsushi Oyagi; Yasuhisa Oida; Kenichi Kakefuda; Masamitsu Shimazawa; Norifumi Shioda; Shigeki Moriguchi; Kiyoyuki Kitaichi; Daisuke Nanba; Kazumasa Yamaguchi; Yasuhide Furuta; Kohji Fukunaga; Shigeki Higashiyama; Hideaki Hara
Journal:  PLoS One       Date:  2009-10-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.